Delivery Order SPE2DX22D0010-SPE2D824FPL02

Award Date 7/25/24
Potential Completion Date 7/26/24
Potential Value $7.4K
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $2,183.13, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The contract is a delivery order for the pharmaceutical product Adzenys XR ODT Tabs 1's 9.4mg. Amerisourcebergen, a major pharmaceutical distributor and healthcare solutions provider, holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,701.66, is a delivery order for the supply of 4,566,828,735 units of Adzenys XR ODT Tabs 1's 9.4mg. The contract has an ultimate completion date of January 6, 2025 and is a firm fixed-price contract. Amerisourcebergen Drug Corp, the prime contractor, is a for-profit...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,404.48 Firm Fixed Price Delivery Order is for the supply of Adzenys XR-ODT 15.7 mg Tablet UD 30s, a medication used to treat various medical conditions. The contract has a completion date of December 17, 2024 and does not have a set-aside designation. AmerisourceBergen holds a significant $999,999,999...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,514.93, is a delivery order for the supply of Adzenys XR-ODT 18.8 mg tablet medication. The contract has an ultimate completion date of January 30, 2025 and is a firm fixed-price contract. This award is not associated with a set-aside designation, indicating open competition. AmerisourceBergen...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,596.44, is for the delivery of Adzenys XR-ODT 15.7 mg tablet units. It is a firm fixed-price delivery order with a completion date of January 14, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, valued at $3,937.60, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Adzenys XR-ODT 9.4 mg tablet in 30-unit doses. This contract is a delivery order under a broader Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026. The IDC enables...
This is a $1,119.16 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ADZENYS XR-ODT 6.3 MG TABLET UD 30S, a prescription medication, with a completion date of February 25, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to supply Adzenys XR-ODT 18.8 mg tablet units. The contract has a firm-fixed price of $1,580.82 and a completion date of September 27, 2024. It is not set aside for any specific business type. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at up to $999,999,999 through December 2025, under...
This federal contract award, valued at $7,022.20, was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order under Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs...
This is a $1,642.02 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ADZENYS XR-ODT 3.1 MG TABLET UD 30S, a pharmaceutical product. The contract has an ultimate completion date of January 21, 2025 and was awarded on January 17, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by...
  • SPE2DX22D0010
    Indefinite Delivery Contract
  • SPE2DX22D0010-SPE2D824FPL02
    Delivery Order

This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Adzenys XR ODT tablets (9.4 mg). The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency, and is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that runs through November 2026. The current contract award is for $7,368.25 and has a completion date of July 26, 2024. The contract has a firm fixed price pricing type and does not utilize any set-aside designations. AmerisourceBergen Drug Corp is the prime contractor for this award, which supports the healthcare needs of military personnel, veterans, and other federal beneficiaries through the supply of essential pharmaceutical products.

Generated 5/17/25, 9:52 AM